跳至主要内容
临床试验/ACTRN12613000445774
ACTRN12613000445774已完成不适用

Th17 response to specific immunotherapy in house dust mite-induced allergic rhinitis patients

i Tian Ying0 个研究点目标入组 50 人开始时间: 2013年4月18日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
50

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Non-randomised trial
主要目的
Treatment

入排标准

年龄范围
20 Years 至 45 Years(—)
性别
All

入选标准

  • Patients were (1) age from 20 to 45 years old; (2) having persistent AR symptoms during the past two consecutive years; (3) allergic sensitization to Dermatophagoides pteronyssinus, (Der p) & Dermatophagoides farina (Der f)) confirmed by both skin prick test (SPT) and ImmunoCap (Registered Trademark) (Phadia, Uppsala, Sweden); (4) no previous treatment of SIT; and (5) negative SPT results to other common inhalant allergens (e.g., common pollens, cockroach, fungi, and animal dander). Healthy subjects without any allergy history and allergic symptoms were selected as a control group.

排除标准

  • All recruited subjects (both allergic rhintis patients and healthy controls) did not have an infection, asthma, autoimmune diseases, or other upper airway diseases such as septal deviation, nasal polyps, or sinusitis before enrolment. Furthermore, all participants had not received any form of steroids or SIT at least six months before the study.

研究者

发起方
i Tian Ying

相似试验

Molecular evidence underlying specific immunotherapy... | 临床试验